Enovix (NASDAQ:ENVX) Stock Jumps 10.9% – Here’s What Happened

Enovix Corporation (NASDAQ:ENVX – Get Free Report) shares traded up 10.9% during mid-day trading on Thursday. The company traded as high as $2.70 and last traded at $2.7050. Approximately 7,719,325 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 6,797,228 shares. The stock had previously closed at $2.44.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ENVX. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research report on Sunday. William Blair cut shares of Enovix from an “outperform” rating to a “market perform” rating in a research report on Monday, August 17th. Northland Securities set a $5.00 target price on Enovix in a research report on Tuesday. Canaccord Genuity Group dropped their price objective on Enovix from $15.00 to $10.00 and set a “buy” rating for the company in a research note on Friday, August 14th. Finally, Craig Hallum set a $7.00 target price on Enovix in a research report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $10.77.

Read Our Latest Report on ENVX

Enovix Price Performance

The firm has a market capitalization of $589.22 million, a PE ratio of -3.31 and a beta of 2.49. The company has a fifty day moving average price of $3.25 and a two-hundred day moving average price of $5.05. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46.

Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. The company had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same period last year, the firm posted ($0.13) EPS. Enovix’s revenue for the quarter was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Sell-side analysts forecast that Enovix Corporation will post -0.80 earnings per share for the current year.

Hedge Funds Weigh In On Enovix

Several institutional investors and hedge funds have recently added to or reduced their stakes in ENVX. BlackRock Inc. purchased a new stake in shares of Enovix in the second quarter valued at approximately $100,054,000. Granahan Investment Management LLC lifted its stake in shares of Enovix by 12.3% in the fourth quarter. Granahan Investment Management LLC now owns 1,964,565 shares of the company’s stock valued at $14,361,000 after purchasing an additional 214,916 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Enovix during the second quarter worth about $8,689,000. Bank of America Corp DE acquired a new stake in shares of Enovix in the 2nd quarter worth approximately $8,356,000. Finally, Bank of New York Mellon Corp acquired a new position in Enovix during the second quarter worth $3,551,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

Recommended Stories

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.